More information on Wright Medical’s foot and ankle products, including the ORTHOLOC™ 3Di Reconstruction Plating System, can be found at www.wmt.com/footandankle/.About Wright Medical Wright Medical Group, Inc. is a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market. The Company specializes in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction. The Company has been in business for more than 60 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the Company’s website at www.wmt.com. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This press release contains “forward-looking statements” as defined under U.S. federal securities laws. These statements reflect management’s current knowledge, assumptions, beliefs, estimates, and expectations and express management’s current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms. Forward-looking statements are subject to a number of risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements. Such risks and uncertainties include the impact of Wright’s settlement of the federal investigation into Wright’s consulting arrangements with orthopaedic surgeons relating to its hip and knee products in the United States, including Wright’s compliance with a Deferred Prosecution Agreement through September 2012 and a Corporate Integrity Agreement through September 2015, and those risks and uncertainties discussed in our filings with the Securities and Exchange Commission (including those described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011, under the heading, “Risk Factors”). Readers should not place undue reliance on forward-looking statements. Such statements are made as of the date of this press release, and we undertake no obligation to update such statements after this date. Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50329548&lang=en
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced the full commercial launch of the ORTHOLOC™ 3Di Reconstruction Plating System for foot and ankle surgery. The system will be available this month in the U.S. through Wright Medical’s specialized foot and ankle sales force, as well as in select countries outside the U.S. through Wright’s direct and distributor-based sales organization.
ORTHOLOC(TM) 3Di Reconstruction Plating System (Photo: Business Wire)The ORTHOLOC™ 3Di Plating System includes a number of anatomical plates, screws and specialized surgical instrumentation used for fracture fixation, osteotomies, and fusions of the foot. This next generation system provides multiple screw options and adds Wright’s ORTHOLOC™ 3Di polyaxial locking technology, which enables the surgeon to adjust the screw trajectory to meet the anatomic requirements of the patient while providing a strong locking construct to promote bone fixation. “The new ORTHOLOC™ 3Di Reconstruction System offers surgeons a wide range of plate designs to address some of the most common procedures performed by foot and ankle surgeons, including bunion reconstruction and fusions of the first toe,” stated Carroll P. Jones, MD, an orthopedic foot and ankle surgeon with OrthoCarolina Foot and Ankle Institute in Charlotte, North Carolina. “The system’s versatility allows surgeons to choose the best screw sizing and placement to create a robust implant construct, which is crucial for proper bone healing.” “Along with other planned new product launches, the ORTHOLOC™ 3Di Plating System is a core foundational portion of our foot and ankle product portfolio and will be key to exiting the year at well above market rates of growth for our foot and ankle business,” said Robert Palmisano, President and Chief Executive Officer of Wright Medical. “We expect to expand this system in the future to treat other areas of the foot, including complex midfoot and hindfoot procedures.”